The research program at Maryland Oncology Hematology, P.A. was established in 2004. It is overseen by Dr. Narang, and focuses on making cancer clinical trials available to this community. Our research studies are for Phase II and III adjuvant and metastatic cancers, as well as expanded access therapeutics. Current programs include therapies for breast, colorectal, lymphoma, ovarian, prostate and lung cancers. These programs allow patients to explore options not yet available to the general market by participating in tests of new drugs, therapies or combinations of treatments.
For further information, please contact your physician or our research department at 410-964-2212 X 1137.
Click here for a list of our current clinical trials.